Key market opportunities in the oral transmucosal drugs sector include expanding use in opioid dependence, seizures, and pain management, driven by needle-free dosing preference and film technology ...

Indian American physician-scientist Dr. Vinod Balachandran says mRNA vaccines may reduce risk of disease coming back after ...

SENIOR-RITA subgroup data showed primary composite events in 37.7% with invasive therapy versus 29.4% with conservative care ...

Care begins moving forward as soon as the visit ends. But often that is only the beginning of the story. Days or weeks later, ...

Discusses Osteoporosis Treatment Landscape and Clinical Potential of EB613 Oral Tablet April 20, 2026 11:00 AM ...

Nothing rivals the human brain's complexity. Its 86 billion neurons and 85 billion other cells make an estimated 100 trillion ...

REMOVING BARRIERS TO PSYCHEDELIC DRUGS AS POTENTIAL TREATMENT FOR SERIOUS MENTAL ILLNESS: Today, President Donald J. Trump signed an Executive Order that ...

By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: Section 1.  Purpose and ...

Background Sex-based differences in immune response are well established, but whether men and women derive comparable benefit ...

The US Food and Drug Administration (FDA) is reviewing a petition to revoke the approval of ocrelizumab for the treatment of ...

Inpatients with indwelling urinary catheters in the general Stroke Ward of the Department of Neurology of our hospital from January to December 2025 were selected as the research subjects. A ...